Table 1.

Mimotopes of tumor-associated antigens.

Target	Ab	Peptide Motif	Reference
CD20	Rituximab	ITPWPHWLERSS	[29]
		QDKLTQWPKWLE	[30]
		WPxWLE (A/S)NPS	[31]
		WAANPS PYANPSL	[33]
		WPKWLE PYANPSL	[34]
EGFR	Cetuximab	CQFDLSTRRLKC CQYNLSSRALKC	[35]
	Cetuximab, Matuzumab	KTL YPLG	[37]
	12H23, Ch806	WHTEILKSYPHE LPAFFVTNQTQD	[38]
	ICR-62	QHYNIVNTQSRV	[39]
	Panitumumab	DTDWVRMRDSAR VPGWSQAFMALA	[41]
ErbB2	Trastuzumab	CQWMAPQWGPDC	[42]
		WxxGxAxGS	[43]
	L26, N12, L288	ALVRYKDPLFVWGFL	[44]
	SER4	INNEYVESPLYM	[45]
PSA	4G5	VDPGKYNKY EGPAKGFKL GCYEAPSKAAKC	[46]
		RRSHPCRTCTTHTP HRKTTCTRCPATSP HRRGECRACPLLPA RRPAHCHHCPRNP	[47]
CEA	Col-1	DRGGLWKTP	[17]
VEGF	Bevacizumab	DHTLYTPYHTHP	[48]
Gastric antigen MGb1	MGb1	HxQ LxS	[49]
Gastric antigen MG7	MG7	NAIYARNAQ TCHLRVYAQ SWAPVYARN	[50]
		KPHVHTK	[51]
		KPHLHFH KPHSHLH SWAPVYARAN	[53]
Human fibrosarcoma cell line	BCD-9	GRRPGGWWMR	[54]
Human B lymphoblastoid cell line	BAT	PRRIKPRKIMLG QKILQQINLPRI	[28,55,56]
Lc4Cer, nLc4Cer	AD117m, H11	RNVPPTFNDVYWIAF	[58]
GD1α	KA17	WHWRHRIPLQLAAGR	[59]
GD2	14G2a	EDPSHSLGLDVALFM	[60,61]
		NCDLLTGPMLCV SCQSTRMDPNCW VCNPLTGALLCS RCNPNMEPPRCF GCDALSGHLLCS	[64]
	ch14.18	CDGGWLSKGSWC CGRLKMVPDLEC	[65,66,67]
	ME361	LDVVLAWRDGLSGAS GVVWRYTAPVHLGDG	[68]
GD3	4F6	LAPPRPRSELVFLSV PHFDSLLYPCELLGC GLAPPDYAERFFLLS RHAYRSMAEWGFLYS	[69]
TF-Ag	JAA-F11	HIHGWKSPLSSL HHSHKTNLATTP GHPHYITHKPNR YPSLPVYHSLRS MHKPWSGHMQVP	[70]
Tumor-specific CD43 glycoforms	UN1	TCKLLDECVPLW SFAATPHTCKLLDEC-VPLWPAEG	[71]